CARL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. While CARL seems to be doing ok healthwise, there are quite some concerns on its profitability. CARL is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year CARL has reported negative net income.

1.2 Ratios

CARL has a worse Return On Assets (-34.45%) than 61.29% of its industry peers.
CARL has a Return On Equity of -43.55%. This is comparable to the rest of the industry: CARL outperforms 52.69% of its industry peers.

		Industry Rank	Sector Rank
ROA	-34.45%
ROE	-43.55%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CARL has a better Gross Margin (74.35%) than 83.87% of its industry peers.
CARL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	74.35%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CARL does not have a ROIC to compare to the WACC, probably because it is not profitable.
CARL has about the same amout of shares outstanding than it did 1 year ago.
CARL has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 6.96 indicates that CARL is not in any danger for bankruptcy at the moment.
CARL's Altman-Z score of 6.96 is amongst the best of the industry. CARL outperforms 83.33% of its industry peers.
CARL has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
CARL's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. CARL outperforms 60.75% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.14
Debt/FCF	N/A
Altman-Z	6.96

ROIC/WACCN/A

WACC9.96%

2.3 Liquidity

CARL has a Current Ratio of 12.03. This indicates that CARL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 12.03, CARL belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
A Quick Ratio of 11.91 indicates that CARL has no problem at all paying its short term obligations.
The Quick ratio of CARL (11.91) is better than 96.24% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	12.03
Quick Ratio	11.91

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CARL have decreased strongly by -31.49% in the last year.
The Revenue has grown by 97.16% in the past year. This is a very strong growth!

EPS 1Y (TTM)-31.49%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)97.16%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

CARL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.12% yearly.
Based on estimates for the next years, CARL will show a very strong growth in Revenue. The Revenue will grow by 27.71% on average per year.

EPS Next Y-30.07%

EPS Next 2Y4.72%

EPS Next 3Y6.18%

EPS Next 5Y9.12%

Revenue Next Year-6.78%

Revenue Next 2Y14.45%

Revenue Next 3Y22.99%

Revenue Next 5Y27.71%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CARL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CARL. No positive earnings are expected for the next year.